Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,025 | 32,630 | 30,952 | 18,173 | 20,398 |
| Receivables | 30,923 | 33,225 | 31,155 | 35,825 | 25,403 |
| Inventories | 8,656 | 10,100 | 11,434 | 11,058 | 11,085 |
| TOTAL | $76,241 | $81,109 | $79,179 | $72,512 | $63,053 |
| Non-Current Assets | |||||
| PPE Net | 484 | 500 | 532 | 546 | 516 |
| Intangibles | 43,578 | 41,430 | 42,201 | 48,711 | 49,958 |
| Other Non-Current Assets | 1,697 | 1,949 | 2,265 | 2,432 | 2,700 |
| TOTAL | $45,759 | $43,879 | $44,998 | $51,689 | $53,174 |
| Total Assets | $122,000 | $124,988 | $124,177 | $124,201 | $116,227 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 10,932 | 16,730 | 10,920 | 11,885 | 5,869 |
| Accounts payable and accrued liabilities | 14,259 | 12,342 | 10,601 | 12,041 | 11,699 |
| Accrued Expenses | 40,156 | 36,700 | 38,164 | 41,727 | 39,372 |
| Other current liabilities | 216 | 221 | 3,379 | 5,053 | 7,108 |
| TOTAL | $65,563 | $65,993 | $63,064 | $70,706 | $64,048 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,998 | 10,447 | 10,895 | 9,535 | 9,983 |
| Other Non-Current Liabilities | 32,238 | 25,377 | 31,252 | 9,062 | 11,431 |
| TOTAL | $42,236 | $35,824 | $42,147 | $18,597 | $21,414 |
| Total Liabilities | $107,799 | $101,817 | $105,211 | $89,303 | $85,462 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,733 | 10,188 | 9,912 | 6,170 | 6,170 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -342,154 | -331,570 | -333,535 | -313,717 | -317,711 |
| TOTAL | $14,201 | $23,171 | $18,966 | $34,898 | $30,765 |
| Total Liabilities And Equity | $122,000 | $124,988 | $124,177 | $124,201 | $116,227 |